Raynaud's phenomenon and chronic/recurrent digital ulcers (DU) are main features of systemic sclerosis (SSc). Their treatment includes both systemic (i.e., iloprost) and local therapies. We report the therapeutic effects of iloprost in a cohort of SSc patients during a long-lasting follow-up period.

Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study / Colaci, M., Lumetti, F., Giuggioli, D., Guiducci, S., Bellando-Randone, S., Fiori, G., Matucci-Cerinic, M., Ferri, C.. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 35 Suppl 106:(2017), pp. 179-183.

Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study

Matucci-Cerinic, Marco;
2017-01-01

Abstract

Raynaud's phenomenon and chronic/recurrent digital ulcers (DU) are main features of systemic sclerosis (SSc). Their treatment includes both systemic (i.e., iloprost) and local therapies. We report the therapeutic effects of iloprost in a cohort of SSc patients during a long-lasting follow-up period.
2017
Adult
Cohort Studies
Female
Humans
Iloprost
Male
Middle Aged
Retrospective Studies
Scleroderma
Systemic
Skin Ulcer
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/154340
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 12
social impact